People: XBiotech Inc (XBIT.OQ)
Mr. John Simard, is Chairman of the Board, President, Chief Executive Officer, Founder of XBiotech Inc. Prior to XBiotech, he was founder and Chief Executive Officer of CTL ImmunoTherapies Corp., a developer of therapeutic vaccines to treat cancer and chronic infectious disease; he also founded of AlleCure Corp., of Valencia, California, a developer of allergy treatments and immune-modulating therapies. In 2001, AlleCure and CTL ImmunoTherapies merged to form MannKind Corp., where Mr. Simard served as Corporate Vice President and board member. Mr. Simard holds a degree in Biochemistry from the University of Saskatchewan and attended graduate studies in Medical Biophysics/Immunology at the University of Toronto.
|Total Annual Compensation, USD||551,380|
|Restricted Stock Award, USD||918,000|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||5,976|
|Fiscal Year Total, USD||1,475,360|